SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001072613-04-000255
Filing Date
2004-02-11
Accepted
2004-02-11 16:00:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 COLLAGENEX PHARMACEUTICALS, INC. SCHEDULE 13G sch13g_12469k.txt SC 13G 7884
  Complete submission text file 0001072613-04-000255.txt   9867
Mailing Address 3801 KENNETT PIKE SUITE B 107 WILMINGTON DE 19807
Business Address 3801 KENNETT PIKE SUITE B 107 WILMINGTON DE 19807 3026551750
ASHFORD CAPITAL MANAGEMENT INC (Filed by) CIK: 0000897070 (see all company filings)

IRS No.: 510243208 | State of Incorp.: DE | Fiscal Year End: 0930

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

IRS No.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47825 | Film No.: 04586384
SIC: 2834 Pharmaceutical Preparations